Human embryonic stem cell-derived mesenchymal stromal cells

Transfusion

Volumn 51, Issue SUPPL. 4, 2011, Pages

  Hematti, Peiman ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; EMBRYONIC STEM CELL; HUMAN; IMMUNOMODULATION; MESENCHYMAL STROMAL CELL; MESENCHYME CELL; STROMA CELL; TREATMENT INDICATION;

ADULT; ADULT STEM CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE II AS TOPIC; COCULTURE TECHNIQUES; EMBRYOID BODIES; EMBRYONIC STEM CELLS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; REGENERATIVE MEDICINE; TISSUE CULTURE TECHNIQUES; TRANSLATIONAL MEDICAL RESEARCH;

EID: 81055147537     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03376.x     Document Type: Article

References (77)

1. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP,. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968; 6: 230-47.
2. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR,. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7. (Pubitemid 29282067)
3. Dominici M, Paolucci P, Conte P, Horwitz EM,. Heterogeneity of multipotent mesenchymal stromal cells: from stromal cells to stem cells and vice versa. Transplantation 2009; 87: S36-42.
4. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH,. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7: 211-28. (Pubitemid 32295155)
5. Williams JT, Southerland SS, Souza J, Calcutt AF, Cartledge RG,. Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am Surg 1999; 65: 22-6. (Pubitemid 29031542)
6. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S,. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A 2000; 97: 13625-30.
7. In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE, Kanhai HH,. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004; 22: 1338-45. (Pubitemid 39636409)
8. Bieback K, Kern S, Kluter H, Eichler H,. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004; 22: 625-34. (Pubitemid 39014578)
9. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM,. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001; 98: 2396-402.
10. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E,. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-7. (Pubitemid 44269669)
11. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R,. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003; 101: 2999-3001. (Pubitemid 36857986)
12. Caplan AI,. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007; 213: 341-7. (Pubitemid 47509711)
13. Keating A,. Mesenchymal stromal cells. Curr Opin Hematol 2006; 13: 419-25. (Pubitemid 44607442)
14. Le Blanc K, Pittenger M,. Mesenchymal stem cells: progress toward promise. Cytotherapy 2005; 7: 36-45. (Pubitemid 40542402)
15. Stagg J, Galipeau J,. Immune plasticity of bone marrow-derived mesenchymal stromal cells. Handb Exp Pharmacol 2007;180: 45-66.
16. Nauta AJ, Fibbe WE,. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007; 110: 3499-506. (Pubitemid 350159613)
17. Le Blanc K, Ringden O,. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 321-34. (Pubitemid 40542924)
18. Prockop DJ, Olson SD,. Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions. Blood 2007; 109: 3147-51. (Pubitemid 46572498)
19. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM,. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-43. (Pubitemid 34534559)
20. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O,. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003; 57: 11-20. (Pubitemid 38019084)
21. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O,. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003; 31: 890-6. (Pubitemid 37211373)
22. Rasmusson I, Ringden O, Sundberg B, Le Blanc K,. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003; 76: 1208-13. (Pubitemid 37339646)
23. Le Blanc K, Gotherstrom C, Ringden O, Hassan M, McMahon R, Horwitz E, Anneren G, Axelsson O, Nunn J, Ewald U, Norden-Lindeberg S, Jansson M, Dalton A, Astrom E, Westgren M,. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 2005; 79: 1607-14. (Pubitemid 40847594)
24. Battiwalla M, Hematti P,. Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy 2009; 11: 503-15.
25. Kim J, Hematti P,. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol 2009; 37: 1445-53.
26. Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Hu X, Jelinek I, Star RA, Mezey E,. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15: 42-9.
27. Block GJ, Ohkouchi S, Fung F, Frenkel J, Gregory C, Pochampally R, DiMattia G, Sullivan DE, Prockop DJ,. Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. Stem Cells 2009; 27: 670-81.
28. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, Semprun-Prieto L, Delafontaine P, Prockop DJ,. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell 2009; 5: 54-63.
29. Oh JY, Roddy GW, Choi H, Lee RH, Ylostalo JH, Rosa RH Jr, Prockop DJ,. Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury. Proc Natl Acad Sci U S A 2010; 107: 16875-80.
30. Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI,. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 1995; 16: 557-64.
31. Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR Jr, Moseley AB, Bacigalupo A,. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005; 11: 389-98. (Pubitemid 40542932)
32. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringden O,. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371: 1579-86. (Pubitemid 351626841)
33. Taupin P,. OTI-010 Osiris Therapeutics/JCR Pharmaceuticals. Curr Opin Investig Drugs 2006; 7: 473-81. (Pubitemid 43772988)
34. Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W,. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002; 30: 215-22. (Pubitemid 35023593)
35. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK,. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309-13. (Pubitemid 29124367)
36. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, Zhang JJ, Chunhua RZ, Liao LM, Lin S, Sun JP,. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004; 94: 92-5. (Pubitemid 38813459)
37. Schuleri KH, Boyle AJ, Hare JM,. Mesenchymal stem cells for cardiac regenerative therapy. Handb Exp Pharmacol 2007: 195-218.
38. Sueblinvong V, Weiss DJ,. Cell therapy approaches for lung diseases: current status. Curr Opin Pharmacol 2009; 9: 268-73.
39. Deda H, Inci MC, Kurekci AE, Sav A, Kayihan K, Ozgun E, Ustunsoy GE, Kocabay S,. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy 2009; 11: 18-25.
40. Bang OY, Lee JS, Lee PH, Lee G,. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005; 57: 874-82. (Pubitemid 40798626)
41. Yoshikawa T, Mitsuno H, Nonaka I, Sen Y, Kawanishi K, Inada Y, Takakura Y, Okuchi K, Nonomura A,. Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg 2008; 121: 860-77. (Pubitemid 351642820)
42. Abdi R, Fiorina P, Adra CN, Atkinson M, Sayegh MH,. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes 2008; 57: 1759-67.
43. Christopeit M, Schendel M, Foll J, Muller LP, Keysser G, Behre G,. Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L. Leukemia 2008; 22: 1062-4. (Pubitemid 351689891)
44. Liang J, Zhang H, Hua B, Wang H, Lu L, Shi S, Hou Y, Zeng X, Gilkeson GS, Sun L,. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis 2010; 69: 1423-9.
45. Giordano A, Galderisi U, Marino IR,. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol 2007; 211: 27-35. (Pubitemid 46363893)
46. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM,. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-7. (Pubitemid 28516247)
47. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O,. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-41. (Pubitemid 38586721)
48. Trivedi P, Hematti P,. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp Hematol 2008; 36: 350-9.
49. Hematti P,. Human embryonic stem cell-derived mesenchymal progenitors: an overview. Methods Mol Biol 2011; 690: 163-74.
50. Xu C, Jiang J, Sottile V, McWhir J, Lebkowski J, Carpenter MK,. Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth. Stem Cells 2004; 22: 972-80. (Pubitemid 39507084)
51. Stojkovic P, Lako M, Stewart R, Przyborski S, Armstrong L, Evans J, Murdoch A, Strachan T, Stojkovic M,. An autogeneic feeder cell system that efficiently supports growth of undifferentiated human embryonic stem cells. Stem Cells 2005; 23: 306-14. (Pubitemid 40404449)
52. Wang Q, Fang ZF, Jin F, Lu Y, Gai H, Sheng HZ,. Derivation and growing human embryonic stem cells on feeders derived from themselves. Stem Cells 2005; 23: 1221-7. (Pubitemid 41504909)
53. Barberi T, Willis LM, Socci ND, Studer L,. Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med 2005; 2: e161.
54. Olivier EN, Rybicki AC, Bouhassira EE,. Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells 2006; 24: 1914-22. (Pubitemid 44474167)
55. Lian Q, Lye E, Suan Yeo K, Khia Way Tan E, Salto-Tellez M, Liu TM, Palanisamy N, El Oakley RM, Lee EH, Lim B, Lim SK,. Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs. Stem Cells 2007; 25: 425-36. (Pubitemid 46232798)
56. Trivedi P, Hematti P,. Simultaneous generation of CD34(+) primitive hematopoietic cells and CD73(+) mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells. Exp Hematol 2007; 35: 146-54. (Pubitemid 46014371)
57. Hwang NS, Varghese S, Zhang Z, Elisseeff J,. Chondrogenic differentiation of human embryonic stem cell-derived cells in arginine-glycine-aspartate- modified hydrogels. Tissue Eng 2006; 12: 2695-706. (Pubitemid 46141292)
58. Choo A, Ngo AS, Ding V, Oh S, Kiang LS,. Autogeneic feeders for the culture of undifferentiated human embryonic stem cells in feeder and feeder-free conditions. Methods Cell Biol 2008; 86: 15-28.
59. Cheng L, Hammond H, Ye Z, Zhan X, Dravid G,. Human adult marrow cells support prolonged expansion of human embryonic stem cells in culture. Stem Cells 2003; 21: 131-42. (Pubitemid 36331756)
60. Karp JM, Ferreira LS, Khademhosseini A, Kwon AH, Yeh J, Langer RS,. Cultivation of human embryonic stem cells without the embryoid body step enhances osteogenesis in vitro. Stem Cells 2006; 24: 835-43. (Pubitemid 44464716)
61. Cao T, Heng BC, Ye CP, Liu H, Toh WS, Robson P, Li P, Hong YH, Stanton LW,. Osteogenic differentiation within intact human embryoid bodies result in a marked increase in osteocalcin secretion after 12 days of in vitro culture, and formation of morphologically distinct nodule-like structures. Tissue Cell 2005; 37: 325-34. (Pubitemid 40932032)
62. Woll NL, Heaney JD, Bronson SK,. Osteogenic nodule formation from single embryonic stem cell-derived progenitors. Stem Cells Dev 2006; 15: 865-79. (Pubitemid 46147858)
63. Bielby RC, Boccaccini AR, Polak JM, Buttery LD,. In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng 2004; 10: 1518-25. (Pubitemid 39557855)
64. Toh WS, Yang Z, Liu H, Heng BC, Lee EH, Cao T,. Effects of culture conditions and bone morphogenetic protein 2 on extent of chondrogenesis from human embryonic stem cells. Stem Cells 2007; 25: 950-60. (Pubitemid 46572592)
65. Sottile V, Thomson A, McWhir J,. In vitro osteogenic differentiation of human ES cells. Cloning Stem Cells 2003; 5: 149-55. (Pubitemid 36877165)
66. zur Nieden NI,. Embryonic stem cells for osteo-degenerative diseases. Methods Mol Biol 2011; 690: 1-30.
67. Alsberg E, von Recum HA, Mahoney MJ,. Environmental cues to guide stem cell fate decision for tissue engineering applications. Expert Opin Biol Ther 2006; 6: 847-66.
68. Yen BL, Chang CJ, Liu KJ, Chen YC, Hu HI, Bai CH, Yen ML,. Brief report-human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes. Stem Cells 2009; 27: 451-6.
69. Sanchez L, Gutierrez-Aranda I, Ligero G, Rubio R, Munoz-Lopez M, Garcia-Perez JL, Ramos V, Real PJ, Bueno C, Rodriguez R, Delgado M, Menendez P,. Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease. Stem Cells 2011; 29: 251-62.
70. Tolar J, Le Blanc K, Keating A, Blazar BR,. Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells 2010; 28: 1446-55.
71. Hematti P,. Role of mesenchymal stromal cells in solid organ transplantation. Transplant Rev (Orlando) 2008; 22: 262-73.
72. English K, French A, Wood KJ,. Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell 2010; 7: 431-42.
73. Thomson JA, Odorico JS,. Human embryonic stem cell and embryonic germ cell lines. Trends Biotechnol 2000; 18: 53-7. (Pubitemid 30084696)
74. Baker M,. FDA to vet embryonic stem cells' safety. Nature 2008; 452: 670. (Pubitemid 351521052)
75. Dihne M, Bernreuther C, Hagel C, Wesche KO, Schachner M,. Embryonic stem cell-derived neuronally committed precursor cells with reduced teratoma formation after transplantation into the lesioned adult mouse brain. Stem Cells 2006; 24: 1458-66. (Pubitemid 44464662)
76. Cai J, Yi FF, Yang XC, Lin GS, Jiang H, Wang T, Xia Z,. Transplantation of embryonic stem cell-derived cardiomyocytes improves cardiac function in infarcted rat hearts. Cytotherapy 2007; 9: 283-91. (Pubitemid 46705868)
77. Arnhold S, Klein H, Semkova I, Addicks K, Schraermeyer U,. Neurally selected embryonic stem cells induce tumor formation after long-term survival following engraftment into the subretinal space. Invest Ophthalmol Vis Sci 2004; 45: 4251-5. (Pubitemid 39564646)